Skip to content
Screener

Aramark ARMK Cash & Equivalents

Cash & Equivalents at other companies

Unifirst logo
UnifirstUNF
$163.23M-23.0%
Cintas logo
CintasCTAS
$289.02M+9.5%
Healthcare Services Group logo
Healthcare Services GroupHCSG
$123.41M+49.0%
ABM Industries logo
ABM IndustriesABM
$94.9M+61.7%
Vail Resorts logo
Vail ResortsMTN
$387.32M-19.4%
Civeo logo
CiveoCVEO
$16.55M-41.7%

Other financials

Income statement

See full
Revenue$4.9B+14.7%
Gross profit$426.4M+18.6%
Operating income$219.7M+26.2%
Net income$102.0M+64.8%
EPS (diluted)$0.38+65.2%

Balance sheet

See full
Total debt$6.5B-10.8%
Total equity$3.3B+8.6%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow-$782.2M-33.2%
CapEx$101.3M-12.5%
Free cash flow-$904.4M-27.9%

Valuation

See full
Market cap$14.96B+44.5%
Enterprise value$20.94B+26.9%
P/E41.9×+13.3×
P/S0.8×+0.2×

Profitability

See full
Gross margin8.4%-0.1pp
Operating margin4.3%-0.1pp
Net margin1.8%-0.1pp
FCF margin1.2%

Returns & leverage

See full
Return on equity11.3%-0.4pp
Debt / equity-0.4×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Aramark in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: Aramark’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001584509-26-000088
Line itemSix Months Ended / April 3, 2026Six Months Ended / March 28, 2025
Repurchase of common stock(66,322)(109,283)
Payments for contingent considerations(33,697)(10,505)
Other financing activities(5,677)(50,816)
Net cash provided by financing activities532,4471,066,564
Effect of foreign exchange rates on cash and cash equivalents and restricted cash(335)(11,497)
(Decrease) Increase in cash and cash equivalents and restricted cash(166,351)241,393
Cash and cash equivalents and restricted cash, beginning of period707,144732,613
Cash and cash equivalents and restricted cash, end of period$540,793$974,006

Item 1. Financial Statements (Unaudited)

FAQ

What is Aramark's cash & equivalents?
Aramark (ARMK) reported cash & equivalents of $540.79M in Q1 2026.
How has Aramark's cash & equivalents changed year-over-year?
Aramark's cash & equivalents decreased by 44.5% year-over-year, from $974.01M to $540.79M.
What is the long-term trend for Aramark's cash & equivalents?
Over 5 years (2020 to 2025), Aramark's cash & equivalents has grown at a -22.4% compound annual growth rate (CAGR), from $2.51B to $707.14M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Aramark's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude